AgNOR Pleomorphic Count as a Tumor Marker in Cervical Carcinogenesis and Feasibility of Its Introduction in Cervical Cancer Screening Programs to Discriminate High-Risk Cases of Squamous Intraepithelial Lesions of the Cervix

Background: AgNOR pleomorphism has been widely used for its diagnostic importance in differentiating premalignant and malignant lesions of different human neoplasms. However, an evaluation of its potential for discriminating cases of high-risk squamous intraepithelial lesions of the cervix (SIL) has been rarely attempted. Aim: The tumor marker potential of AgNOR pleomorphism counts was assessed by correlating high and low mean counts in low-grade SIL (LSIL) cases with persistence or regression of the lesion and HPV positivity. Materials and Methods: The 115 LSIL cases selected for the study were registered from the ongoing cervical cancer screening of the rural population of Lucknow West. Silver nitrate staining for AgNOR counts and HPV DNA testing were done in all 115 cases. Results: The AgNOR counts in the 115 LSIL cases revealed low counts in 92 and high counts in 23 cases. Follow-up, available in 107 cases, revealed persistence of the lesion in 21 of the 23 cases with high counts and in 4 of the 84 cases with low counts. HPV positivity showed a strong correlation with high counts. Persistence of LSIL was also more frequent with high AgNOR counts and in HPV-positive cases. Conclusions: The study showed a correlation of high mean AgNOR counts with HPV positivity and persistence of LSIL.

[1]  V. Sharma,et al.  Evaluation of AgNORs in gallbladder lesions , 2017 .

[2]  M. Astekar,et al.  Analysis of silver binding nucleolar organizer regions in exfoliative cytology smears of potentially malignant and malignant oral lesions , 2017, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[3]  Kuldeep Singh,et al.  Evaluation of AgNORs on FNA smears and tissue sections in benign and malignant breast diseases , 2016 .

[4]  A. Hassan,et al.  Micronuclei and Ag NOR as Biomarker in Fine Needle Aspiration Cytology of Breast Tumor , 2016 .

[5]  Sathyavathi R. Alva,et al.  Silver stained Nucleolar organizer regions in nonneoplastic and neoplastic lesions of endometrium , 2016 .

[6]  Komal Khot,et al.  Pleomorphism of argyrophilic nucleolar organizer regions in oral submucous fibrosis and oral squamous cell carcinoma , 2015, Journal of natural science, biology, and medicine.

[7]  S. Srivastava,et al.  Diagnostic importance of AgNOR pleomorphism in cervical carcinogenesis , 2013, Ecancermedicalscience.

[8]  B. Illades-Aguiar,et al.  AgNOR polymorphism association with squamous intraepithelial lesions and invasive carcinoma with HPV infection. , 2009, Salud publica de Mexico.

[9]  N. Malathi,et al.  Argyrophilic nucleolar organizer regions in inflammatory, premalignant, and malignant oral lesions: a quantitative and qualitative assessment. , 2008, Indian journal of dental research : official publication of Indian Society for Dental Research.

[10]  V. Das,et al.  Assessment of potential of AgNOR counts as tumor marker in cervical carcinogenesis , 2008, Diagnostic cytopathology.

[11]  M. Gamboni,et al.  Usefulness of ploidy, AgNOR and immunocytochemistry for differentiating benign and malignant cells in serous effusions , 2007, Cytopathology : official journal of the British Society for Clinical Cytology.

[12]  Y. Shukla,et al.  Silver-Stained Nucleolar Organizer Regions in Normal and Dysplastic Cervical Lesions: Correlation with DNA Ploidy and S-Phase Fraction by Flow Cytometry , 2007, Oncology.

[13]  V. Das,et al.  AgNOR counts in cervical smears under normal and other cytopathologic conditions. , 2005, Analytical and quantitative cytology and histology.

[14]  A. Khanna,et al.  Nucleolar organizer region count and subjective AgNOR pattern assessment (SAPA) score in skin tumors , 2001, Journal of surgical oncology.

[15]  L. W. Shih,et al.  Silver staining method for nucleolar organizer regions in cervical smears , 1997, Diagnostic cytopathology.

[16]  D. Treré,et al.  AgNOR protein quantity of cervical smears correlates with that of histological sections in cervical intraepithelial neoplasia. , 1997, European journal of histochemistry : EJH.

[17]  D. Prathiba,et al.  Value of AgNORS in premalignant and malignant lesions of the cervix. , 1995, Indian journal of pathology & microbiology.

[18]  Diane Solomon,et al.  The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991. , 1993, Acta cytologica.

[19]  P. Barbini,et al.  Prognostic factors in invasive cervical carcinomas associated with human papillomavirus (HPV). Quantitative data and cytokeratin expression. , 1992, Pathology, research and practice.

[20]  M. Cardillo.  AgNOR counts are useful in cervical smears , 1992, Diagnostic cytopathology.

[21]  S. Polacarz,et al.  Nucleolar organiser regions in adenocarcinoma in situ and invasive adenocarcinoma of the cervix. , 1990, Journal of clinical pathology.

[22]  M. Wells,et al.  A Study of Nucleolar Organizer Regions in Cervical Intraepithelial Neoplasia and Human Papillomavirus Infection , 1989, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[23]  J. Crocker,et al.  Intraepithelial neoplasia, human papilloma virus infection and argyrophilic nucleoprotein in cervical epithelium , 1988, Histopathology.

[24]  D. Rowlands,et al.  Nucleolar organising regions in cervical intraepithelial neoplasia. , 1988, Journal of clinical pathology.